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Merchant et al., by using ung+ and
ung– Escherichia coli strains, demon-
strated that total nitric oxide expo-
sures in the µmol/L range can lead to
C→T mutations by a mechanism
probably involving cytosine deamina-
tion (8). On the other hand, in M.
smegmatis, the abrogation of the Ung
activity leads not only to increased
mutator phenotype but also to growth
inhibition by reactive nitrogen inter-
mediates (7). In summary, I speculate
that mutations in ung that do not com-
pletely impair function, but do
decrease synthesis of its product,
might tolerably increase the sponta-
neous C→T mutations, including
those in the respective positions in the
rpoB codons 531 and 526. This
assumption seems likely because both
of the aforementioned particular
mutations were described in sponta-
neous mutants of H37Rv obtained in
vitro and had a Darwinian fitness
slightly less than or equal to that of
the  rpoB wild-type-susceptible
parental strain (9). In contrast, the
translesion synthesis-based pathways
appear less likely to contribute to
emergence of such mutants, although
at least one of the translesion synthe-
sis genes (dinP) is present in the
genome of M. tuberculosis. In the E.
coli in vitro model, a translesion syn-
thesis enzyme (dinB encoded DNA
polymerase IV) activity clearly pro-
moted more important frameshift
mutations (single-base deletions) in
two thirds of the spontaneous mutants
(10).
From an evolutionary point of
view, the multiple rpoB mutations in
M. tuberculosis have been hypothe-
sized to arise as a compensatory
mechanism to ameliorate the fitness
costs of the original resistance muta-
tion by a secondary mutation (11).
The process of adaptation to the fit-
ness costs of chromosomally encoded
resistance has been studied in E. coli
and  Salmonella enterica serovar
Typhi for mutations that affect trans-
lation in the rpsL and fusR genes (11)
and for rpoB mutations in E. coli K12
strain (11). In the last instance, the
rpoB multiple mutants were selected
in vitro in a stepwise fashion, and one
double mutant, L511Q+D516G (also
described in M. tuberculosis strain
[3]), exhibited a relative fitness either
greater than or equal to either single
mutant or the wild type. Reynolds
(11) suggested that this allele is
favored not merely as a combination
of two low-level resistance mutations
but also because these mutations
together boost resistance and preserve
fitness. Whether the same is true for
other multiple mutant alleles in M.
tuberculosis rpoB remains to be seen.
Studying the costs of resistance of
multiple  rpoB mutations in a more
realistic environment of animal mod-
els of TB infection seems promising.
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Human
Metapneumovirus
and Chronic
Obstructive
Pulmonary Disease 
To the Editor: We read with inter-
est an article, Human Meta-
pneumovirus Detection in Patients
with Severe Acute Respiratory
Syndrome, in your journal (1). In the
report, Chan et al., did not question
that SARS-CoV is the etiologic agent
of severe acute respiratory syndrome
(SARS); however, human metapneu-
movirus (HMPV) was found in 25
(52%) of 48 probable SARS cases that
were investigated, and SARS-CoV
was detected in 11 (22.9%) of them.
Another recent article reported
HMPV in five of six patients in whom
SARS was diagnosed in Canada (2);
four of the six were coinfected with
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SARS-CoV. The prevalence of
HMPV infection in SARS patients
validates the interest in HMPV’s pos-
sible role in SARS etiology.
From November 2001 to February
2002, 1 year before the first cases of
SARS appeared, we tested the sputum
of patients >64 years of age who had
experienced exacerbation of chronic
obstructive pulmonary disease, for
HMPV. Investigations were conduct-
ed on 90 episodes in 89 elderly
patients, 62 males and 27 females, in
which we found no other microorgan-
isms that could have been related to
the exacerbation of chronic obstruc-
tive pulmonary disease. RNA was
extracted from the sputum samples
and amplified by reverse transcrip-
tase–polymerase chain reaction (RT-
PCR) to detect HMPV as previously
described (3). Results of bacterial cul-
ture and culture and PCR to detect
respiratory syncytial virus and
influenza virus types A and B were
negative, whereas HMPV was found
in the sputum of five (three men and
two women) immunocompetent
patients, 77–87 years of age. The
prevalence of HMPV infection was
5.5%, similar to the percentage
obtained by Chan et al., when HMPV
RT-PCR was conducted on the respi-
ratory samples. Fever (temperature
>38ºC) was not present in any of the
five patients infected with HMPV.
Two patients were admitted to a hos-
pital. Both patients had bronchial
infection and cough with bron-
chospasm and moderate respiratory
insufficiency (oxygen saturation rate:
90.3% and 88%, respectively) for >1
week. Sputum samples from an addi-
tional 70 elderly patients with exacer-
bation of chronic obstructive pul-
monary disease with positive detec-
tion for influenza virus (n = 50) or res-
piratory syncytial virus (n = 20) were
tested for HMPV infection. None of
the samples showed HMPV infection.
Sequence analysis of amplicons
from the five samples positive for
HMPV infection showed >95% simi-
larity with HMPV sequences found in
other parts of the world (4,5).
Additional studies should be conduct-
ed to confirm that HMPV exacerbates
chronic obstructive pulmonary dis-
ease. However, by performing an RT-
PCR directly on the sample instead of
the more efficient RT-PCR after viral
culture used by Chan et al., these find-
ings suggest that HMPV is a frequent-
ly undetected agent in acute respirato-
ry infection unrelated to SARS. The
important questions are whether
HMPV and SARS-CoV coinfection
would facilitate more severe SARS,
or whether HMPV infection would
facilitate a more efficient transmission
of SARS-CoV. 
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Integrons in
Salmonella
Keurmassar,
Senegal 
To the Editor: Infections caused
by Salmonella are the primary cause
of foodborne diseases; multidrug
resistance to Salmonella enterica
subsp. enterica  is increasing. The
selective pressure created by the
widespread use of antimicrobial
agents in animals and humans as pro-
phylactic and therapeutic agents may
have contributed to the dissemination
of resistant bacterial strains. In 2000,
the new serovar Keurmassar
(35:c:1,2) of S. enterica, was
described in Senegal (1). Integrons
are efficient gene-capture systems by
site-specific recombination and are
involved in antimicrobial-drug resist-
ance in gram-negative bacteria (2).
Three classes of integrons are well
characterized and are involved in
antimicrobial resistance. Integrons
have been found in different nonty-
phoidal serovars of S. enterica and
recently in serovar Typhi (3).
We evaluated the contribution of
integrons to the antimicrobial drug
resistance of eight isolates of S.
enterica serovar Keurmassar sent to
the Senegalese National Salmonella
and Shigella Reference Laboratory at
the Pasteur Institute in Dakar from
March to May 2000. One strain was
isolated from poultry flesh, and seven
strains were isolated from human
stool or blood samples. Susceptibility
testing was performed by disk diffu-
sion method on Mueller-Hinton agar
according to the Comité de l’antibi-
ogramme, Société Française de
Microbiologie, recommendations.
The eight strains expressed an
extended-spectrum  β-lactamase,
which was previously identified as
SHV-12 (1). The strains were also
resistant to aminoglycosides
(amikacin, gentamicin, netilmicin,
spectinomycin, streptomycin, and
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